MGNX
Income statement / Annual
Last year (2024), MacroGenics, Inc.'s total revenue was $148.34 M,
an increase of 159.37% from the previous year.
In 2024, MacroGenics, Inc.'s net income was -$66.97 M.
See MacroGenics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$148.34 M |
$57.19 M |
$150.02 M |
$75.64 M |
$97.76 M |
$62.02 M |
$60.12 M |
$155.52 M |
$86.58 M |
$100.85 M |
| Cost of Revenue |
$12.30 M
|
$8.22 M
|
$7.38 M
|
$2.65 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$136.04 M
|
$48.97 M
|
$142.63 M
|
$72.99 M
|
$97.76 M
|
$62.02 M
|
$60.12 M
|
$155.52 M
|
$86.58 M
|
$100.85 M
|
| Gross Profit Ratio |
0.92
|
0.86
|
0.95
|
0.96
|
1
|
1
|
1
|
1
|
1
|
1
|
| Research and Development Expenses |
$177.19 M
|
$166.58 M
|
$207.03 M
|
$214.58 M
|
$193.20 M
|
$195.31 M
|
$190.83 M
|
$147.23 M
|
$122.09 M
|
$98.27 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$42.74 M
|
$46.06 M
|
$40.50 M
|
$32.65 M
|
$29.83 M
|
$22.77 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$71.05 M
|
$52.19 M
|
$58.95 M
|
$63.01 M
|
$42.74 M
|
$46.06 M
|
$40.50 M
|
$32.65 M
|
$29.83 M
|
$22.77 M
|
| Other Expenses |
-$1.62 M
|
-$1.56 M
|
-$1.92 M
|
-$1.80 M
|
-$7.12 M
|
-$2.16 M
|
-$247.00 K
|
$2.52 M
|
$1.51 M
|
$42.00 K
|
| Operating Expenses |
$246.62 M
|
$217.22 M
|
$264.05 M
|
$275.79 M
|
$228.82 M
|
$239.21 M
|
$231.33 M
|
$177.66 M
|
$146.62 M
|
$121.04 M
|
| Cost And Expenses |
$258.92 M
|
$225.44 M
|
$271.44 M
|
$278.44 M
|
$228.82 M
|
$239.21 M
|
$231.33 M
|
$177.66 M
|
$146.62 M
|
$121.04 M
|
| Interest Income |
$9.42 M
|
$9.69 M
|
$1.70 M
|
$680.00 K
|
$800.00 K
|
$3.40 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$1.12 M
|
$1.43 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$7.54 M
|
$9.65 M
|
$11.87 M
|
$11.26 M
|
$11.96 M
|
$12.31 M
|
$9.20 M
|
$7.23 M
|
$7.61 M
|
$2.86 M
|
| EBITDA |
-$57.37 M |
$2.02 M |
-$107.89 M |
-$190.86 M |
-$119.10 M |
-$164.88 M |
-$162.05 M |
-$12.40 M |
-$50.92 M |
-$17.32 M |
| EBITDA Ratio |
-0.39
|
0.04
|
-0.72
|
-2.52
|
-1.22
|
-2.66
|
-2.7
|
-0.08
|
-0.59
|
-0.17
|
| Operating Income Ratio |
-0.75
|
-2.94
|
-0.81
|
-2.68
|
-1.34
|
-2.86
|
-2.85
|
-0.14
|
-0.69
|
-0.2
|
| Total Other Income/Expenses Net |
$44.56 M
|
$159.19 M
|
$1.66 M
|
$680.00 K
|
$1.32 M
|
$25.37 M
|
-$247.00 K
|
$2.52 M
|
$1.51 M
|
$42.00 K
|
| Income Before Tax |
-$66.02 M
|
-$9.06 M
|
-$119.76 M
|
-$202.12 M
|
-$129.74 M
|
-$151.81 M
|
-$171.45 M
|
-$19.63 M
|
-$58.53 M
|
-$20.14 M
|
| Income Before Tax Ratio |
-0.45
|
-0.16
|
-0.8
|
-2.67
|
-1.33
|
-2.45
|
-2.85
|
-0.13
|
-0.68
|
-0.2
|
| Income Tax Expense |
$944.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$247.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$66.97 M
|
-$9.06 M
|
-$119.76 M
|
-$202.12 M
|
-$129.74 M
|
-$151.81 M
|
-$171.45 M
|
-$19.63 M
|
-$58.53 M
|
-$20.14 M
|
| Net Income Ratio |
-0.45
|
-0.16
|
-0.8
|
-2.67
|
-1.33
|
-2.45
|
-2.85
|
-0.13
|
-0.68
|
-0.2
|
| EPS |
-1.07 |
-0.15 |
-1.95 |
-3.18 |
-2.25 |
-3.16 |
-4.19 |
-0.54 |
-1.69 |
-0.63 |
| EPS Diluted |
-1.07 |
-0.15 |
-1.95 |
-3.18 |
-2.25 |
-3.16 |
-4.19 |
-0.54 |
-1.69 |
-0.63 |
| Weighted Average Shares Out |
$62.62 M
|
$61.93 M
|
$61.41 M
|
$59.94 M
|
$52.44 M
|
$48.08 M
|
$40.93 M
|
$36.10 M
|
$34.69 M
|
$31.80 M
|
| Weighted Average Shares Out Diluted |
$62.62 M
|
$61.93 M
|
$61.43 M
|
$59.94 M
|
$52.44 M
|
$48.08 M
|
$40.93 M
|
$36.10 M
|
$34.69 M
|
$31.80 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
